AbbVie wins FDA approval for new antibiotic to treat complex intra-abdominal infections

The FDA approved AbbVie and Pfizer’s drug Emblaveo in combination with an older antibiotic to treat complicated intra-abdominal infections.

AbbVie, which owns the US commercial …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Cattle testing for H5N1 bird flu will be more limited than USDA initially announced

New federal rules aimed at limiting the spread of the H5N1 bird flu virus among dairy cattle go into effect Monday, but detailed guidance documents

April 26, 2024

FDA ships two Form 483s to Dr. Reddy’s for two separate sites in India

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 22, 2024

Boston Scientific’s drug-coated balloon may reduce risk of heart attack

A drug-coated balloon made by Boston Scientific reduced the risk of heart attack in patients with complications from stents, researchers reported on Wednesday. Boston Scientific

October 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.